---
schema_version: "secwatch.filing_event.v1"
accession: "0000310764-21-000108"
form_type: "8-K"
ticker: "SYK"
cik: "0000310764"
company_name: "STRYKER CORP"
filed_at: "2021-07-27T23:59:59+00:00"
generated_at: "2026-06-30T02:18:24.579994+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Stryker Q2 net sales $4.3B (+55% YoY), raises FY2021 guidance

## Summary
- Reported net sales $4.3B, +55.4% from 2020 and +17.6% from 2019; organic net sales +42.9% from 2020.
- Reported EPS $1.55; adjusted EPS $2.25 (up from $0.64 in Q2 2020).
- Adjusted operating income margin 25.9% vs reported 17.0%.
- Orthopaedics $1.6B (+82.3%), MedSurg $1.7B (+32.3%), Neuro/Spine $0.9B (+66.9%) from 2020.
- Raises FY2021 outlook: organic net sales growth 9-10% from 2019; adj. EPS $9.25-$9.40.

## SEC filing metadata
- accession: 0000310764-21-000108
- form_type: 8-K
- ticker: SYK
- cik: 0000310764
- company_name: STRYKER CORP
- filed_at: 2021-07-27T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/310764/000031076421000108/0000310764-21-000108-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/310764/000031076421000108/syk-20210727.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000310764-21-000108
- JSON: https://secwatch.observer/filing/0000310764-21-000108.json
- Plain text: https://secwatch.observer/filing/0000310764-21-000108.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.